Spirograficheskie kharakteristiki patsientov s KhOBL i metabolicheskim sindromom v zavisimosti ot massy tela
https://doi.org/10.14341/2071-8713-4980
Abstract
It is known that low body mass index is a statistically significant predictor of death rate in patients with COPD. The purpose of
our research comprised in evaluation of peculiarities of respiratory function parameters in patients with COPD and metabolic syndrome
depending on body mass index. All patients were divided into groups: those who have only COPD, those who have combination of COPD
and metabolic syndrome, they were subdivided into 3 subgroups, depending on body mass index (with normal body mass index, excess
body mass index, and obesity). As a result of the research, it was found out that emphysematous respiratory disorders prevailed among
patients with COPD and normal body mass index. Symptoms of obstructive bronchitis were found in patients with combination of COPD
and metabolic syndrome, and excess body mass index values.
our research comprised in evaluation of peculiarities of respiratory function parameters in patients with COPD and metabolic syndrome
depending on body mass index. All patients were divided into groups: those who have only COPD, those who have combination of COPD
and metabolic syndrome, they were subdivided into 3 subgroups, depending on body mass index (with normal body mass index, excess
body mass index, and obesity). As a result of the research, it was found out that emphysematous respiratory disorders prevailed among
patients with COPD and normal body mass index. Symptoms of obstructive bronchitis were found in patients with combination of COPD
and metabolic syndrome, and excess body mass index values.
References
1. Авдеев С.Н. Хроническая дыхательная недостаточность // Сonsilium medicum 2004; 4: P. 263-269.
2. Айсанов З.Р., Кокосов А.Н., Овчаренко С.И., Хмелькова Н.Г., Цой А.Н., Чучалин А.Г., Шмелев Е.И. Хронические обструктивные болезни легких. Федеральная программа МЗ РФ // РМЖ 2001; P. 1: 9-33.
3. Березин А.Е. Хроническая обструктивная болезнь легких и кардиоваскулярный риск // Украинский медицинский журнал «Часопис» 2009; 2 (70); P. 62-68.
4. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению // РМЖ 2001; 2: P. 56-60.
5. Global initiative for Chronic Obstructive Lung Disease global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease (Updated 2008) // National Institutes of Health. National Heart, Lung and Blood Institute. http://www.goldcopd.com.
6. Попова Т.Н. Особенности клинико-лабораторных проявлений и нутритивного статуса у больных ХОБЛ в сочетании с метаболическим синдромом: Автореф. дис… канд. мед. наук. Тюмень, 2009.
7. Синдром «Х» - «Метаболический синдром» (Состояние высокого риска) // Методические рекомендации РУДН, М. 2005; 39 http://promedec.narod.ru.
8. Соколова С.Ю. Клинические, иммунологические и бактериологические про- явления хронической обструктивной болезни легких на фоне ожирения: Дис… канд. мед. наук. Самара, 2007.
9. Чучалин А.Г. Хроническая обструктивная болезнь легких и сопутствующие за- болевания. Часть I. ХОБЛ и поражения сердечно-сосудистой системы // РМЖ 2008;16(2);58. http://www.rmj.ru.
10. Чучалин А.Г. Хроническая обструктивная болезнь легких и сопутствующие за- болевания. Часть II. ХОБЛ и некардиальные поражения // РМЖ 2008; 16 (5);246. http://www.rmj.ru.
11. Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPD // Eur. Respir. J. 2008; 32(4): P. 962-969.
12. Roussos C., Respiratory muscle and ventilatore failure // Chest 1990; 97: S 89-96.
Review
For citations:
, , Spirograficheskie kharakteristiki patsientov s KhOBL i metabolicheskim sindromom v zavisimosti ot massy tela. Obesity and metabolism. 2010;7(3):28-30. (In Russ.) https://doi.org/10.14341/2071-8713-4980
Views:
495
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
